Guarding against digestive-system cancers: Unveiling the role of Chk2 as a potential therapeutic target
Yucheng An1, Duolun Gao1, Yanjie He2
1Department of Gastroenterology, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110004, China.
Abstract:
Digestive-system cancers represent major threats to human health; however, the mechanisms underlying tumorigenesis and radiochemotherapy resistance have remained elusive. Therefore, an urgent need exists for identifying key drivers of digestive system tumorigenesis and novel targeted therapeutics. The checkpoint kinase 2 (Chk2) regulates cell-cycle progression, and Chk2 dysregulation or Chk2 mutations can lead to the development of various cancers, which makes Chk2 an important research topic. This review summarizes the roles of Chk2 in DNA-damage responses, cell-cycle regulation, autophagy, and homeostasis maintenance. We describe relationships between tumorigenesis and cell-cycle dysregulation induced by Chk2 mutations. In addition, we summarize evidence indicating that Chk2 can serve as a novel therapeutic target, based on its contributions to radiochemotherapy-resistance reversion and progress made in developing antitumor agents against Chk2. The prevailing evidence supports the conclusion that further research on Chk2 will provide a deeper understanding of digestive-system tumorigenesis and should suggest novel therapeutic targets.
Insights
Checkpoint kinase 2 (Chk2) plays a key role in digestive system cancer development and treatment resistance. Targeting Chk2 offers a promising strategy for novel digestive cancer therapies.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Digestive system cancers pose significant health risks, with underlying mechanisms of tumorigenesis and treatment resistance poorly understood.
- Checkpoint kinase 2 (Chk2) is crucial for cell-cycle regulation and DNA-damage response, making its dysregulation a factor in cancer development.
Purpose of the Study:
- To review the multifaceted roles of Chk2 in cellular processes relevant to cancer.
- To explore the link between Chk2 mutations, cell-cycle dysregulation, and digestive system tumorigenesis.
- To evaluate Chk2 as a potential therapeutic target for overcoming radiochemotherapy resistance.
Main Methods:
- Literature review synthesizing current research on Chk2 function.
- Analysis of Chk2's involvement in DNA-damage response, cell-cycle control, autophagy, and homeostasis.
- Examination of evidence linking Chk2 to tumorigenesis and therapeutic resistance.
Main Results:
- Chk2 dysregulation and mutations are associated with cell-cycle abnormalities driving tumorigenesis.
- Chk2 influences DNA repair, cell cycle progression, autophagy, and tissue homeostasis.
- Evidence suggests Chk2 inhibition can reverse radiochemotherapy resistance.
Conclusions:
- Chk2 is a critical regulator implicated in digestive system cancer initiation and progression.
- Targeting Chk2 presents a viable therapeutic avenue for enhancing cancer treatment efficacy.
- Further investigation into Chk2 mechanisms will illuminate digestive tumorigenesis and guide novel therapeutic strategies.
Related Concept Videos
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
02:34Inhibition of Cdk Activity
02:15M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
02:38Mitogens and the Cell Cycle
01:12Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...